No Detail Found!

Effect of Jiawei qingxuan jiangya decoction on blood pressure variability and sex hormone levels in perimenopausal female patients with hypertension

Author(s)
Yaqin Pan Yuncheng Central Hospital, Hedong Street, Yanhu District, Yuncheng City, Shanxi Province, China
Rong Li Yuncheng Central Hospital, Hedong Street, Yanhu District, Yuncheng City, Shanxi Province, China
Xin Li Yuncheng Central Hospital, Hedong Street, Yanhu District, Yuncheng City, Shanxi Province, China
Jie Wang Yuncheng Central Hospital, Hedong Street, Yanhu District, Yuncheng City, Shanxi Province, China
Abstract
To explore the effect of Jiawei Qingxuan Jiangya Decoction on blood pressure variability and sex hormone levels in perimenopausal women with hypertension. A total of 400 perimenopausal female hypertensive patients admitted to the hospital from June 2019 to June 2020 were randomly divided into observation group and control group, with 200 cases in each group. The patients in the control group took orally benazepril hydrochloride tablets, and the observation group was added with Jiawei Qingxuan Jiangya Decoction on the basis of the control group. The course of treatment was 1 month. The clinical efficacy of the two groups and the 24h blood pressure variability (BPV) and sex hormone levels before and after treatment were compared. The total effective rate of the observation group was significantly higher than that of the control group (P<0.05); the 24h BPV of the two groups after treatment was significantly lower than that before the treatment, and the reduction in the observation group was greater (P<0.05); the serum estradiol in the observation group after treatment was significantly increased, and the level of follicle stimulating hormone was significantly reduced, and compared with the control group after treatment, the difference was statistically significant (P<0.05). Jiawei Qingxuan Jiangya Decoction for treating hypertension in perimenopausal women can effectively reduce blood pressure, improve short-term blood pressure variability, regulate sex hormone levels to a certain extent, and correct endocrine disorders. It is worthy of clinical promotion.
Publication Details
Page(s) 365-368
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: S1, Year: 2022

Request the full text from PASTIC

Keywords
Hypertension, online health education, Jiawei qingxuan jiangya, Management
References
Alejandro DLS,Mateu A,Gorostidi M,Vinyoles E,Segura J,Ruilope LM .2021 .Antihypertensive therapy and short-term blood pressure variability. J. Hypertens, 39(2) : 349-355.
Fan SH,Chen HS,Chen SX,Hou XL .2018 .Study on the correlation between 137 cases of perimenopausal hypertension and traditional Chinese medicine physique. Hebei J. Trad. Chin. Med, 40(5) : 55-50.
Kang J,Zhao XS,Ding YN .2015 .The effect of blood pressure variability on carotid atherosclerosis in elderly women with hypertension. Chin. J. Geriatric. Cardiovascul. Cerebrovascul. Dis., 17(2) : 200-202.
Khalid AM,Mohammed N,Ahmed EO,Sherif R .2018 .Electrochemical determination of amlodipine besilate and benazepril hydrochloride in their binary mixture using pvc and coated graphite sensors. Int. J. Sci., 5(4) : 28-32.
Schumacher H Ley L .2013 .Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients). Curr. Med. Res. Opin., 29(1) : 41-53.
Li Z Li J .2018 .Research progress in traditional Chinese and Western medicine on the pathogenesis of perimenopausal hypertension. Hunan J. Trad. Chin. Med, 34(3) : 182-184.
Li M,Jin LL .2019 .Observation on the clinical efficacy of TCM treatment of female menopausal hypertension from liver differentiation. J. Guangzhou Univ. Trad. Chin. Med, 36(4) : 30-34.
Li W and Li G .2018 .Key points of Chinese expert consensus on diagnosis and treatment of elderly hypertension (2017 Edition). Chin. J. Hypert., 26(10) : 986-989.
Liu JM .2017 .Modified erxian decoction in the treatment of 86 cases of perimenopausal hypertension. Yunnan J. Trad. Chin Med, 38(5) : 51-52.
Majnaric LT,Martinovi I,Abanovi E,Rudan S,Wittlinger T,Martinovic I,Sefket Šabanovic,Stjepan R,Frantisek B,Thomas W .2019 .The effect of hypertension duration and the age of onset on CV risk factors expression in perimenopausal women. Int. J. Hypertens., : 1-9.
Ning F .2020 .Evaluation of the effect of health education based on the information of wisdom and medicine on the management of patients with essential hypertension. Medical Diet and Health, 18(7) : 182-184.
Shi YJ,Qian WD .2019 .Research progress of traditional Chinese and western medicine on female menopausal hypertension. Xinjiang. Trad. Chin. Med, 183(5) : 80-82.
Song SJ .2018 .Qingxuan jiangya decoction combined with irbesartan in the treatment of 30 cases of perimenopausal essential hypertension. Chin National Folk Med, 27(11) : 109-111.
Sverre K,Giuseppe M,Roland S,Michaela M,Thomas U .2013 .An update on telmisartan/ hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors. Expert. Rev. Cardiovasc. Ther., 11(6) : 673-682.
Tian ZX .2018 .The effect of Qingxuan jiangya decoction combined with western medicine treatment on blood pressure and blood lipids in patients with simple hypertension of yin deficiency and yang hyperactivity. Sichuan. Trad. Chin. Med, 36(10) : 86-89.
Zhang JN,Yang CH .2017 .Modified erxian decoction in the treatment of female menopausal hypertension. J. Integrated Trad. Chin. West Med, 15(16) : 2066-2067.
Zheng XY .2021 .Guidelines for clinical research on new traditional Chinese medicines [M]. China Med, : .
0

Citations

0

Downloads

11

Views